News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
379,373 Results
Type
Article (14933)
Company Profile (121)
Press Release (364312)
Multimedia
Podcasts (53)
Webinars (10)
Section
Business (113315)
Career Advice (476)
Deals (18770)
Drug Delivery (42)
Drug Development (31427)
Employer Resources (55)
FDA (8868)
Job Trends (7759)
News (173862)
Policy (12439)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (3)
Academia (1340)
Accelerated approval (12)
Allergies (82)
Alliances (35074)
ALS (45)
Alzheimer's disease (642)
Antibody-drug conjugate (ADC) (189)
Approvals (9088)
Artificial intelligence (481)
Autoimmune disease (79)
Automation (39)
Bankruptcy (131)
Best Places to Work (6551)
BIOSECURE Act (7)
Biosimilars (37)
Biotechnology (88)
Bladder cancer (64)
Brain cancer (32)
Breast cancer (284)
Cancer (2338)
Cardiovascular disease (160)
Career advice (438)
Career pathing (13)
CAR-T (210)
CDC (9)
Cell therapy (515)
Cervical cancer (24)
Clinical research (26151)
Collaboration (1329)
Company closure (1)
Compensation (253)
Complete response letters (8)
COVID-19 (1239)
CRISPR (95)
C-suite (537)
Cystic fibrosis (61)
Data (2818)
Decentralized trials (1)
Denatured (26)
Depression (46)
Diabetes (221)
Diagnostics (5224)
Digital health (41)
Diversity (7)
Diversity, equity & inclusion (10)
Drug discovery (186)
Drug pricing (23)
Drug shortages (4)
Duchenne muscular dystrophy (94)
Earnings (41020)
Editorial (9)
Employer branding (8)
Employer resources (50)
Events (53917)
Executive appointments (580)
FDA (10573)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (6)
Frontotemporal dementia (9)
Funding (959)
Gene editing (183)
Generative AI (40)
Gene therapy (365)
GLP-1 (311)
Government (1293)
Grass and pollen (3)
Guidances (224)
Healthcare (10005)
HIV (29)
Huntington's disease (14)
IgA nephropathy (28)
Immunology and inflammation (72)
Immuno-oncology (23)
Indications (61)
Infectious disease (1399)
Inflammatory bowel disease (83)
Inflation Reduction Act (5)
Influenza (84)
Intellectual property (166)
Interviews (58)
IPO (8112)
IRA (11)
Job creations (1463)
Job search strategy (378)
JPM (21)
Kidney cancer (6)
Labor market (30)
Layoffs (148)
Leadership (10)
Legal (2540)
Liver cancer (45)
Longevity (9)
Lung cancer (259)
Lymphoma (182)
Machine learning (37)
Management (21)
Manufacturing (580)
MASH (37)
Medical device (11911)
Medtech (11972)
Mergers & acquisitions (11332)
Metabolic disorders (425)
mRNA (120)
Multiple sclerosis (66)
NASH (3)
Neurodegenerative disease (139)
Neuropsychiatric disorders (20)
Neuroscience (1140)
NextGen: Class of 2026 (3554)
Non-profit (1554)
Now hiring (15)
Obesity (153)
Opinion (106)
Ovarian cancer (96)
Pain (112)
Pancreatic cancer (109)
Parkinson's disease (131)
Partnered (21)
Patents (328)
Patient recruitment (278)
Peanut (35)
People (33976)
Pharmaceutical (20)
Pharmacy benefit managers (4)
Phase 1 (9619)
Phase 2 (11745)
Phase 3 (7630)
Pipeline (3108)
Policy (67)
Postmarket research (504)
Preclinical (4305)
Press Release (66)
Prostate cancer (107)
Psychedelics (6)
Radiopharmaceuticals (187)
Rare diseases (336)
Real estate (3433)
Recruiting (26)
Regulatory (10556)
Reports (21)
Research institute (1327)
Resumes & cover letters (71)
Rett syndrome (23)
RNA editing (9)
RSV (43)
Schizophrenia (33)
Series A (180)
Series B (113)
Service/supplier (6)
Sickle cell disease (35)
Special edition (1)
Spinal muscular atrophy (62)
Sponsored (21)
Startups (2545)
State (2)
Stomach cancer (2)
Supply chain (50)
Tariffs (11)
The Weekly (26)
Vaccines (528)
Venture capital (47)
Weight loss (54)
Women's health (56)
Worklife (3)
Date
Today (14)
Last 7 days (332)
Last 30 days (1408)
Last 365 days (14837)
2026 (2818)
2025 (15172)
2024 (18811)
2023 (22256)
2022 (31026)
2021 (32677)
2020 (30733)
2019 (25965)
2018 (19548)
2017 (18940)
2016 (17817)
2015 (20629)
2014 (15222)
2013 (12771)
2012 (13805)
2011 (14096)
2010 (12842)
Location
Africa (330)
Alabama (71)
Alaska (6)
Arizona (188)
Arkansas (11)
Asia (25059)
Australia (4421)
California (5581)
Canada (1742)
China (578)
Colorado (299)
Connecticut (255)
Delaware (113)
Europe (51448)
Florida (982)
Georgia (233)
Hawaii (2)
Idaho (34)
Illinois (500)
India (41)
Indiana (277)
Iowa (8)
Japan (295)
Kansas (103)
Kentucky (20)
Louisiana (20)
Maine (22)
Maryland (752)
Massachusetts (3745)
Michigan (292)
Minnesota (427)
Mississippi (5)
Missouri (102)
Montana (29)
Nebraska (16)
Nevada (54)
New Hampshire (85)
New Jersey (1672)
New Mexico (18)
New York (1495)
North Carolina (827)
North Dakota (9)
Northern California (2394)
Ohio (182)
Oklahoma (17)
Oregon (24)
Pennsylvania (1060)
Puerto Rico (19)
Rhode Island (36)
South America (522)
South Carolina (64)
South Dakota (1)
Southern California (2404)
Tennessee (111)
Texas (924)
United States (20870)
Utah (204)
Vermont (1)
Virginia (97)
Washington D.C. (19)
Washington State (521)
West Virginia (3)
Wisconsin (92)
Wyoming (1)
379,373 Results for "agilent technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System
January 26, 2026
·
3 min read
Press Releases
Agilent Showcases Next‑Generation Automated Solutions at SLAS2026
February 5, 2026
·
4 min read
Press Releases
Agilent Reports First-Quarter Fiscal Year 2026 Financial Results
February 26, 2026
·
19 min read
Press Releases
Agilent to Participate in TD Cowen’s 46th Annual Health Care Conference
February 24, 2026
·
1 min read
Press Releases
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award
February 11, 2026
·
2 min read
Press Releases
Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25
February 3, 2026
·
1 min read
Press Releases
Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025
·
1 min read
Press Releases
Agilent to Participate in Citi’s 2025 Global Healthcare Conference
November 19, 2025
·
1 min read
Press Releases
Agilent Announces Cash Dividend of 25.5 Cents Per Share
November 20, 2025
·
1 min read
Press Releases
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)
February 11, 2026
·
3 min read
1 of 37,938
Next
